Detalhe da pesquisa
1.
Lack of efficacy of mTOR inhibitors and ACE pathway inhibitors as antifibrotic agents in evolving and established fibrosis in Mdr2â»/â» mice.
Liver Int
; 35(4): 1451-63, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-24517519
2.
Rapamycin inhibits hepatic fibrosis in rats by attenuating multiple profibrogenic pathways.
Liver Transpl
; 15(10): 1315-24, 2009 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-19790156